Stay updated on G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page.

Latest updates to the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded a funding note '2017 ( U.S. NIH Grant/Contract )' under the study identifiers and updated the page revision from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a newer page revision. This is a metadata update rather than a substantive change to the study information.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision tag on the page changed from v3.6.3 to v3.6.4, indicating a minor site revision rather than changes to study data or displayed content.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, representing a new software release for the page infrastructure. There are no changes to the study details, eligibility criteria, or other content on the page.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the page. This reflects a newer release of the site template used for listing and presenting study details.SummaryDifference0.0%

- Check93 days agoChange DetectedThe updates indicate recruitment status is closed and introduce new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) while adjusting the Intervention/Treatment header and removing an older revision tag.SummaryDifference0.4%

Stay in the know with updates to G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the G1T48 Alone & With Palbociclib in ER+ Advanced Breast Cancer Clinical Trial page.